The International Journal of Gynecological Cancer publishes content on novel and relevant topics in the field of gynecologic cancer. IJGC Podcast features short interview segments with leading experts discussing the latest research in their respective areas. The podcasts will serve as an interactive and education experience for all our listeners. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Sexual Harassment in Gynecologic Oncology with Marina Stasenko
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Marina Stasenko to discuss sexual harassment in gynecologic oncology. Dr. Stasenko is a practicing gynecologic oncologist at the NYU Langone Hospital and recently completed her fellowship at the Memorial Sloan Kettering Cancer Center.
Highlights from the podcast:
- 64% of all gynecologic oncologist surveyed reported experience of sexual harassment in training or in practice.
- Only 14.5% reported the behavior.
- Female respondents were more likely to report that gender affected their career and compensation.
- Male respondents were more likely to report no gender disparity in income.
Reviewing the October Issue with Florencia Noll (Spanish Version)
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the September issue of IJGC in Spanish.
Reviewing the October Issue with Sadie Jones and Navya Nair (English Version)
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the October issue of IJGC.
Impact of Uterine Manipulator in Endometrial Cancer with Pablo Padilla-Iserte
Pablo Padilla-Iserte, MD, PhD, is a gynecologic oncologist working at the Department of Gynecologic Oncology. La Fe University and Polytechnic Hospital, Valencia (Spain), ESGO Accredited Center. She specializes in oncological surgery, especially in minimally invasive approach and education programs for fellowship and residents.
ERAS Global Survey with Gregg Nelson and Geetu Bhandoria
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Gregg Nelson and Geetu Bhandoria to discuss the ERAS Global Survey. Their article, "Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practice” (https://ijgc.bmj.com/content/early/2020/08/28/ijgc-2020-001683), is the Lead Article in the October 2020 of IJGC.
Dr. Gregg Nelson is Professor and Chief of Gynecologic Oncology at the Tom Baker Cancer Centre in Calgary, Alberta, Canada. His main research interest is the development and study of Enhanced Recovery After Surgery (ERAS) protocols in cancer and ObGyn surgery. Dr. Nelson is Secretary of the ERAS Society.
Dr. Geetu Bhandoria is a Gynecologic Oncologist and obstetrician at Command Hospital in Pune, India. He as completed fellowship in Gynecologic Oncology. His research interests are advanced ovarian cancer, enhanced recovery protocols and the use of social media as a research tool. He is also currently serving as one of IJGC’s Editorial Fellows.
Hospital Volume and Outcomes in Early Cervical Cancer with Emeline Aviki
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Emeline Aviki to discuss hospital volume and outcomes in early cervical cancer. Dr. Emeline Aviki, MD, MBA is a Gynecologic Oncologist at Memorial Sloan Kettering Cancer Center and former research fellow in the health outcomes research group at MSKCC. Dr. Aviki's research focus is in health outcomes and care delivery innovation to improve the affordability of care for patients.